Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status
出版年份 2020 全文链接
标题
Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status
作者
关键词
-
出版物
BMC GASTROENTEROLOGY
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-06-10
DOI
10.1186/s12876-020-01298-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside
- (2019) Trond Espen Detlie et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
- (2018) N. Franklin Adkinson et al. AMERICAN JOURNAL OF HEMATOLOGY
- Review article: treating-to-target for inflammatory bowel disease-associated anaemia
- (2018) Laurent Peyrin-Biroulet et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Blood and Bone Loser
- (2017) Benedikt Schaefer et al. GASTROENTEROLOGY
- A controlled study of the effects of ferric carboxymaltose on bone and haematinic biomarkers in chronic kidney disease and pregnancy
- (2017) Louis L Huang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
- (2016) Benedikt Schaefer et al. PLoS One
- High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23
- (2016) Jens Frederik Dahlerup et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial
- (2016) Matthew A. Roberts et al. BMC Nephrology
- European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
- (2015) Axel U Dignass et al. Journal of Crohns & Colitis
- Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?
- (2013) Peter L. Havens et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs
- (2013) Edward R. Smith et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
- (2013) Myles Wolf et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Review article: vitamin D and inflammatory bowel disease - established concepts and future directions
- (2012) M. Garg et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease
- (2012) Rayko Evstatiev et al. Clinical Gastroenterology and Hepatology
- FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease
- (2011) Rayko Evstatiev et al. GASTROENTEROLOGY
- A rapid infusion protocol is safe for total dose iron polymaltose: time for change
- (2010) M. Garg et al. INTERNAL MEDICINE JOURNAL
- A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial
- (2008) Stefanie Kulnigg et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started